mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.002 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.003 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |